We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

LY 294002

Potent Inhibitor of Phosphatidylinositol 3-Kinases

  • Cell-permeable
  • Specifically inhibits PI 3-kinases
  • Supplied as a dried powder

Size

Catalog number selected: V1201

$ 150.00 Your price: Log in

Add to Helix
LY 294002
5mg
$ 150.00
Your price: Log in

LY 294002 [2-(4-Morpholinyl)-8-phenyl-4 H-1-benzopyran-4-one] is a potent and specific cell-permeable inhibitor of phosphatidylinositol 3-kinases (PI 3-kinases) with IC50 values in the 1–50μM range. LY 294002 competitively inhibits ATP binding to the catalytic subunit of PI 3-kinases and does not inhibit PI 4-kinase, DAG-kinase, PKC, PKA, MAPK, S6 kinase, EGFR or c-src tyrosine kinases and rabbit kidney ATPase. The chemical identity and purity of LY 294002 is confirmed by proton NMR and elemental analysis.

LY 294002 is supplied as a dried powder. Resuspend 5mg in 325μl DMSO to produce a 50mM stock solution.

References

  1. Rameh, L.E. and Cantley, L.C. (1999) J. Biol. Chem. 274, 8347–50.
  2. Fruman, D.A. et al. (1998) Annu. Rev. Biochem. 67, 481–507.
  3. Vlahos, C. et al. (1995) J. Immunol. 154, 2413–22.
  4. Vlahos, C. et al. (1994) J. Biol. Chem. 269, 5241–8.

Specifications

What's in the box?

Item Part # Size

LY 294002

V120A 1 × 5mg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Store at –20°C in the dark, ideally in a nonfrost-free freezer.

Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom